undamentalytics Newsletter
Sign in

Fortrea Holdings Inc. income statement

In fiscal 2025, Fortrea Holdings Inc. reported revenue of $2.72bn, up 1.0% on the year before, operating income of −$873m (a -32.0% margin) and net income of −$986m, or −$10.81 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue3,0582,8372,8432,6962,7232,667
Selling, general and administrative303416448561456409
Operating income11418732−162−87313
Interest expense0070———
Net interest income—−0−70———
Income before tax136187−31−275−983−53
Income tax38411−4316
Net income98186−25−329−986−69
Diluted EPS$1.10$2.09−$0.29−$3.67−$10.81—
Diluted shares (average)89m89m89m90m——
EBITDA281281130−75−79592

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BIO vs FTREFTRE vs MEDPFTRE vs QGEN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Fortrea Holdings Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Fortrea Holdings Inc.